DUAL GLP-1 AND GIP RECEPTOR AGONIST PHARMACEUTICAL COMPOSITION AND USE THEREOF

Title:

DUAL GLP-1 AND GIP RECEPTOR AGONIST PHARMACEUTICAL COMPOSITION AND USE THEREOF

Document Type and Number:

WIPO Patent Application WO/2024/061310

Kind Code:

A1

Abstract:

The present invention provides a dual GLP-1 and GIP receptor agonist pharmaceutical composition, comprising a dual GLP-1 and GIP receptor agonist, a stabilizer, and a buffer salt. The present invention also provides a use of the pharmaceutical composition in the preparation of a drug for preventing and/or treating metabolic disorder related diseases.

More Like This:

WO/2021/057541	EXENATIDE ANALOG
WO/2015/183038	COMPOSITION FOR TREATING DIABETES, CONTAINING LONG-ACTING INSULIN ANALOG CONJUGATE AND LONG-ACTING INSULIN SECRETION PEPTIDE CONJUGATE
WO/2004/000354	METHOD OF TREATING THE SYNDROME OF LIPODYSTROPHY

Inventors:

LI HUIFANG (CN)
FENG XIN (CN)
ZHANG BO (CN)
ZHENG FANGFANG (CN)
LI JIAHAN (CN)
SHENG PANPAN (CN)

Application Number:

PCT/CN2023/120363

Publication Date:

March 28, 2024

Filing Date:

September 21, 2023

Export Citation:

Click for automatic bibliography generation Help

Assignee:

BRIGHTGENE BIO MEDICAL TECH CO LTD (CN)
BRIGHTGENE PHARMACEUTICAL SUZHOU CO LTD (CN)

International Classes:

A61K38/26; A61P3/10; C07K14/605

Foreign References:

CN115124602A	2022-09-30
CN112312926A	2021-02-02
CN107207576A	2017-09-26
CN112351994A	2021-02-09
CN106554403A	2017-04-05

Attorney, Agent or Firm:

LINDA LIU & PARTNERS (CN)

Download PDF:

View/Download PDF PDF Help

Previous Patent: DEFECT IDENTIFICATION METHOD AND APPARATUS, COMPUTER DEVICE, AND STORAGE MEDIUM

Next Patent: MODEL TRAINING METHOD AND APPARATUS, AND IMAGE CLASSIFICATION METHOD AND APPARATUS